$0.93-0.06 (-5.93%)
Health In Tech, Inc.
Health In Tech, Inc. in the Technology sector is trading at $0.93 with a market capitalization of $63M. Wall Street consensus targets $3.70 (3 analysts), implying a +297.3% move over the next 12 months. The stock is currently near its 52-week low of $0.85, remaining 27.3% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: MACD remains below its signal line. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $8.77Mβ | $7.51Mβ | $8.49Mβ | $9.31Mβ | $8.01M |
| Gross Profit | $4.51Mβ | $4.13Mβ | $5.14Mβ | $6.31Mβ | $5.36M |
| Operating Income | -$2.16Mβ | -$170,813β | $493,523β | $725,070β | $480,658 |
| Net Income | -$1.59Mβ | -$302,557β | $452,176β | $630,631β | $498,592 |
Health In Tech, Inc. operates as an insurance technology platform company in the United States. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; SMR, a...

CEO Johnson projects A-rated carrier status could boost financials 20% to 30%.

Moby summary of Health In Tech, Inc.'s Q2 2026 earnings call
Despite a temporary revenue dip from carrier onboarding, the company's robust pipeline and new platform initiatives signal strong future expansion.

Health In Tech (NASDAQ:HIT) reported second-quarter revenue of $8.1 million, down 13.5% from $9.3 million in the year-earlier period, as the company said the onboarding of a new carrier shifted certain policy effective dates into later quarters. Chief Executive Officer Tim Johnson said the revenue
Moby summary of Health In Tech, Inc.'s Q1 2026 earnings call